detailed safety analysis from the destiny-breast04 trial
Published 1 year ago • 134 plays • Length 6:33Download video MP4
Download video MP3
Similar videos
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
5:02
reflections on the destiny-breast04 trial | patricia lorusso
-
2:30
patient-reported outcomes from destiny-breast04
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
5:45
her2-positive breast cancer: a paradigm shift in diagnosis and therapy
-
11:12
her2-low breast cancer: destiny or good science?
-
4:18
asco 2022: destiny-breast04, paloma-2, reecur
-
4:07
safety follow-up of the randomized, phase 3 study destiny-breast03
-
3:31
asco daily news 2022 plenary update - lba3: destiny-breast04
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
5:11
destiny-breast04: t-dxd provides significant improvement in os pfs in her2-low mbc
-
4:25
destiny-breast03: safety follow-up results
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
1:10
destiny-04: her2 1 /fish- metastatic breast cancer tdxd treatment | jane meisel, md | asco22 updates
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
2:05
tropion-breast04: dato-dxd and durvalumab in tnbc or hr-low/her2- breast cancer
-
0:48
highlights from esmo: destiny-breast03
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms